Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...

Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...

A new study suggests that people with epilepsy associated with head injuries, especially the type not well controlled by medication, are more likely to have other health conditions like depression, ...

Researchers have identified a potential treatment target for a genetic type of epilepsy. Researchers at the Francis Crick Institute, UCL and MSD have identified a potential treatment target for a ...

HAMPTON ROADS, Va. - According to the Epilepsy Foundation, nearly half a million children aged 14 and under are living with epilepsy, a brain condition that causes seizures. Dravet syndrome is a rare ...

A new study suggests that people with epilepsy associated with head injuries, especially the type not well controlled by medication, are more likely to have other health conditions like depression, ...

The researchers of a single-center study found that the relationships between epilepsy and autoimmune diseases may be a result of the different etiopathogenetic mechanisms that underly seizure ...

Epilepsy is a disorder of the brain that affects the nervous system. Epilepsy causes abnormal electrical activity in the brain, which leads to seizures. There are many types of seizure medication, all ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO – For persons with epilepsy, cognitive impairment was reduced for those with the generalized form of the ...

Children and young adults with a rare, debilitating type of epilepsy experienced half as many seizures while taking a cannabinoid drug, found a new study. A small handful of the study participants ...

SGLT-2 inhibitor use, compared with DPP-4 inhibitor use, was associated with a lower incidence of epilepsy among patients with type 2 diabetes. The use of sodium-glucose cotransporter 2 (SGLT-2) ...